BLFS – the most advanced company for biopreservation media products!
Zacks small-cap research - Demand for biopreservation media is estimated to grow at an
annual rate of almost 20% over the next several years,
largely driven by rapid growth of the emerging field of
regenerative medicine (including cell therapy and tissue
engineering, according to MedMarket Diligence . Another study, from Visiongain, also supports a robust outlook for regenerative medicine and predicts this market
will grow from $1.4 billion in 2012 to $10 billion in 2020 (~28% CAGR).
BioLife expects to benefit from the emerging field of regenerative medicine and is positioning their HypoThermosol and CryoStor products as a better
alternative to other branded biopreservation media and home-brews.
Sentiment: Buy